RTA, also known as GLP-3, targets three distinct receptors: GLP-1 (appetite suppression), GIP (insulin secretion), and glucagon (increased energy expenditure and fat burning).
While standard GLP-1 medications target one pathway and dual agonists like TRZ (GLP-2) target two, these triple agonists add glucagon to boost calorie burn.
This compound is for research use only and not for human use or consumption.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Bundle and save! Get each 10mg vial of RTA for only $80 each when you buy a full pack of 10 vials.
RTA, also known as GLP-3, targets three distinct receptors: GLP-1 (appetite suppression), GIP (insulin secretion), and glucagon (increased energy expenditure and fat burning).
While standard GLP-1 medications target one pathway and dual agonists like TRZ (GLP-2) target two, these triple agonists add glucagon to boost calorie burn.
This compound is for research use only and not for human use or consumption.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.